Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Total Liabilities (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Total Liabilities for 6 consecutive years, with $3.8 million as the latest value for Q3 2018.

  • Quarterly Total Liabilities fell 6.41% to $3.8 million in Q3 2018 from the year-ago period, while the trailing twelve-month figure was $3.8 million through Sep 2018, down 6.41% year-over-year, with the annual reading at $3.4 million for FY2017, 59.58% down from the prior year.
  • Total Liabilities hit $3.8 million in Q3 2018 for Armata Pharmaceuticals, up from $3.4 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $70.5 million in Q1 2014 to a low of $3.1 million in Q1 2018.
  • Historically, Total Liabilities has averaged $16.0 million across 5 years, with a median of $7.7 million in 2017.
  • Biggest five-year swings in Total Liabilities: crashed 85.39% in 2016 and later soared 33.14% in 2017.
  • Year by year, Total Liabilities stood at $23.2 million in 2014, then tumbled by 70.29% to $6.9 million in 2015, then grew by 22.37% to $8.4 million in 2016, then crashed by 59.58% to $3.4 million in 2017, then increased by 10.54% to $3.8 million in 2018.
  • Business Quant data shows Total Liabilities for ARMP at $3.8 million in Q3 2018, $3.4 million in Q2 2018, and $3.1 million in Q1 2018.